SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public):
SEC Accession No. 0001145549-24-002777
Filing Date
2024-01-24
Accepted
2024-01-24 13:08:49
Documents
2
Period of Report
2023-11-30

Document Format Files

Seq Description Document Type Size
1 primary_doc.html NPORT-P  
1 primary_doc.xml NPORT-P 26821
2 NPORT-EX kt_xdna.htm NPORT-EX 48721
  Complete submission text file 0001145549-24-002777.txt   77150

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001873280      
Series S000073961   Kelly CRISPR & Gene Editing Technology ETF
Class/Contract C000231237   Kelly CRISPR & Gene Editing Technology ETF XDNA
Mailing Address 7887 EAST BELLEVIEW AVE.,SUITE 1100 DENVER CO 80111
Business Address 7887 EAST BELLEVIEW AVE.,SUITE 1100 DENVER CO 80111 212-951-0499
Strategic Trust (Filer) CIK: 0001873280 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: NPORT-P | Act: 40 | File No.: 811-23723 | Film No.: 24555485